Researcher.Life Logo

Neuropsychiatric Disease and Treatment : Impact Factor & More

eISSN: 1178-2021pISSN: 1176-6328
JournalOpen Access

Key Metrics

CiteScore
4.5
Impact Factor
< 5
SJR
Q3Biological Psychiatry
SNIP
1.09
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Neuropsychiatric Disease and Treatment

Neuropsychiatric Disease and Treatment Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher DOVE MEDICAL PRESS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2836
Publication Time16
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2005
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Neuropsychiatric Disease and Treatment ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Neuropsychiatric Disease and Treatment

Elucidating Biological Links in Autism Spectrum Disorder: From Blood-Based Risk Factor Identification to a Validated Nomogram for Early Risk Stratification
  • 17 Jan 2026
  • Neuropsychiatric Disease and Treatment
Sertraline for the Treatment of Major Depressive Disorder in the US: Effectiveness and Acceptability in Real-World Practice
  • 15 Jan 2026
  • Neuropsychiatric Disease and Treatment
Targeting Programmed Cell Death in Depression: A Review of Traditional Chinese Medicine Interventions Based on Preclinical Evidence
  • 14 Jan 2026
  • Neuropsychiatric Disease and Treatment
Psychosocial and Biological Factors Associated with Non-Suicidal Self-Injury in Chinese Child and Adolescent Inpatients with Major Depressive Disorder
  • 1 Jan 2026
  • Neuropsychiatric Disease and Treatment
Association Between Glymphatic Dysfunction and Anxiety in Parkinson’s Disease: Insights from DTI-ALPS and Choroid Plexus Volume
  • 1 Jan 2026
  • Neuropsychiatric Disease and Treatment
Flaxseed Supplementation Confers Resilience to Stress-Induced Depression-Like Behaviors via GDNF Epigenetic Modulation in the Ventral Tegmental Area of Rats
  • 1 Jan 2026
  • Neuropsychiatric Disease and Treatment
Elucidating Biological Links in Autism Spectrum Disorder: From Blood-Based Risk Factor Identification to a Validated Nomogram for Early Risk Stratification
  • 17 Jan 2026
  • Neuropsychiatric Disease and Treatment
Sertraline for the Treatment of Major Depressive Disorder in the US: Effectiveness and Acceptability in Real-World Practice
  • 15 Jan 2026
  • Neuropsychiatric Disease and Treatment
Targeting Programmed Cell Death in Depression: A Review of Traditional Chinese Medicine Interventions Based on Preclinical Evidence
  • 14 Jan 2026
  • Neuropsychiatric Disease and Treatment
Psychosocial and Biological Factors Associated with Non-Suicidal Self-Injury in Chinese Child and Adolescent Inpatients with Major Depressive Disorder
  • 1 Jan 2026
  • Neuropsychiatric Disease and Treatment
Association Between Glymphatic Dysfunction and Anxiety in Parkinson’s Disease: Insights from DTI-ALPS and Choroid Plexus Volume
  • 1 Jan 2026
  • Neuropsychiatric Disease and Treatment
Flaxseed Supplementation Confers Resilience to Stress-Induced Depression-Like Behaviors via GDNF Epigenetic Modulation in the Ventral Tegmental Area of Rats
  • 1 Jan 2026
  • Neuropsychiatric Disease and Treatment

FAQs on Neuropsychiatric Disease and Treatment